¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reticular inhibitory area"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peripheral inhibitory field
    ¸»ÃʾïÁ¦¿µ¿ª
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • annular reticular fiber
    °í¸®±×¹°¼¶À¯
  • intralaminar reticular nucleus
    ¼¶À¯ÆÇ¼Ó±×¹°ÇÙ, ÆÇ³»¸Á»óÇÙ
  • pontine tegmental reticular nucleus
    ´Ù¸®³úµÚÆÇ±×¹°ÇÙ, ±³³úÇǰ³¸Á»óÇÙ
  • paramedian reticular nucleus
    Á¤Áß°ç±×¹°ÇÙ, Á¤Áß°ç¸Á»óÇÙ
  • reticular
    ±×¹°-, ¸Á»ó-
  • reticular acropigmentation
    ±×¹°¸»´Ü»ö¼ÒÄ§Âø
  • reticular atrophy
    ±×¹°À§Ãà, ¸Á»óÀ§Ãà
  • reticular cell
    ±×¹°¼¼Æ÷, ¸Á»ó¼¼Æ÷
  • reticular degeneration
    ±×¹°º¯¼º, ¸Á»óº¯¼º
  • reticular dermis
    ±×¹°ÁøÇÇ, ¸Á»óÁøÇÇ
  • reticular fiber
    ±×¹°¼¶À¯, ¸Á»ó¼¶À¯
  • reticular formation
    ±×¹°Ã¼, ¸Á»óü
  • reticular keratitis
    ±×¹°°¢¸·¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subareolar area
    Á¥²ÉÆÇ¹ØºÎÀ§, À¯·ûÇϺÎ
  • supporting area
    ÁöÁöºÎ
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory synapse
    ¾ïÁ¦¿¬Á¢
  • inhibitory transmitter
    ¾ïÁ¦Àü´Þ¹°
  • inhibitory postsynaptic potential
    ¾ïÁ¦½Ã³ÀÈÄÀüÀ§, ¾ïÁ¦¿¬Á¢ÈÄÀüÀ§
  • annular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
  • reticular acropigmentation
    ±×¹°¸»´Ü»ö¼ÒÄ§Âø
  • reticular anastomosis
    ±×¹°¿¬°á, ¸Á»ó¿¬°á
  • reticular atrophy
    ¸Á»óÀ§Ãà
  • reticular cell
    ±×¹°¼¼Æ÷
  • reticular degeneration
    ±×¹°º¯¼º
  • reticular density
    ¸Á»óÀ½¿µ, ±×¹°À½¿µ
  • reticular dermis
    ¸Á»óÁøÇÇ
  • reticular fiber
    ±×¹°¼¶À¯, ¸Á»ó¼¶À¯
  • reticular formation
    ±×¹°Ã¼
  • intralaminar reticular nucleus
    ¼¶À¯ÆÇ¼Ó±×¹°ÇÙ
  • reticular keratitis
    ±×¹°°¢¸·¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory concentration, minimum (MIC)
    ¾ïÁ¦ÃÖ¼Ò³óµµ
  • inhibitory effect
    ¾ïÁ¦È¿°ú(åäð¤ Íý).
  • inhibitory effect
    ¾ïÁ¦È¿°ú.
  • inhibitory enzyme
    ÀúÇØÈ¿¼Ò.
  • inhibitory hormone
    ¾ïÁ¦(åäð¤)È£¸£¸ó.
  • inhibitory junctional potential
    ¾ïÁ¦¼º Á¢ÇÕºÎÀü¾Ð(ïÈùêݬï³äâ).
  • inhibitory nerve
    ¾ïÁ¦½Å°æ(åäð¤ãêÌè).
  • inhibitory nerve
    ¾ïÁ¦½Å°æ.
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory synapse
    ¾ïÁ¦¼º(åäð¤àõ) ½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º.
  • inhibitory transmitter
    ¾ïÁ¦¼º Àü´Þ¹°Áú.
  • inhibitory zone
    ¾ïÁ¦¹üÀ§(åäð¤ÛôêÌ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º(åäð¤àõ) ½Ã³³½º.
  • inhibitory transmitter
    ¾ïÁ¦¼º Àü´Þ¹°Áú.
  • inhibitory zone
    ¾ïÁ¦¹üÀ§(åäð¤ÛôêÌ).
  • luteotrop(h)ic hormone inhibitory factor =LTHIF
    ȲüÀÚ±ØÈ£¸£¸ó¾ïÁ¦ÀÎÀÚ(üÜô÷ô§Ð½¡­åäð¤ì×í­).
  • lymphocyte inhibitory factor (LIF)
    ¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
  • macrophage migration inhibitory factor
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ.
  • migration inhibitory factor =MIF
    ´ë½Ä¼¼Æ÷À¯ÁÖÀúÁöÀÎÀÚ(ÓÞãÝá¬øàë´ñËîÁ ò­ì×í­).
  • migratory inhibitory factor
    À̵¿¼º ¾ïÁ¦ÀÎÀÚ
  • minimal inhibitory concentration
    ÃÖÀú¹ßÀ°ÀúÁö³óµµ(õÌî¸Û¡ëÀðæò­ÒØöô).
  • minimum inhibitory concentration
    ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(õÌá³Û¡ëÀîÁò­ÒØöô).
  • minimum inhibitory concentration
    ÃÖ¼Ò¾ïÁ¦³óµµ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Anterior amygdaloid area
    ¾ÕÆíµµ±¸¿ª
    [¿¾ ¿ë¾î] ÀüÆíµµÃ¼¾ß
  • Area of facial nerve
    ¾ó±¼½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ¾È¸é½Å°æ¾ß
  • Retro-olivary area
    ¿Ã¸®ºêµÚ±¸¿ª
    [¿¾ ¿ë¾î] ¿Ã¸®ºêÈĺÎÀ§
  • Disc area
    ¿ø¹Ý±¸¿ª
    [¿¾ ¿ë¾î] ¿ø¹ÝºÎ
  • Superior vestibular area
    À§¾È¶ã½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] »óÀüÁ¤¾ß
  • Paraterminal area
    Á¾¸»ÆÇ¿·±¸¿ª
    [¿¾ ¿ë¾î] Á¾ÆÇ¹æ¾ß
  • Area cribrosa
    ü±¸¿ª
    [¿¾ ¿ë¾î] »ç»ó¾ß
  • Cribrose area
    ü±¸¿ª
    [¿¾ ¿ë¾î] »ç»ó¾ß
  • Area pellucida
    Åõ¸í±¸¿ª
    [¿¾ ¿ë¾î] ¸í¾ß[ºÎ]
  • Formative area
    Çü¼º±¸¿ª
    [¿¾ ¿ë¾î] Çü¼º¾ß[ºÎ]
  • Arcuate area
    Ȱ²Ã±¸¿ª
    [¿¾ ¿ë¾î] ±Ã»óºÎ
  • Absorbing area
    Èí¼ö±¸¿ª
    [¿¾ ¿ë¾î] Èí¼öºÎ
  • Lateral reticular nucleus
    °¡Âʱ׹°ÇÙ
    [¿¾ ¿ë¾î] ¿ÜÃø¸Á»óüÇÙ
  • Gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] °Å´ë¼¼Æ÷Áß°£¸Á»óüÇÙ
  • Reticular membrane
    ±×¹°¸·
    [¿¾ ¿ë¾î] ¼¼¸Á¸·
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • posterior hypothalamic area
    ÈĽûóÇϺοµ¿ª
  • premotor area
    Àü¿îµ¿¿µ¿ª
  • saddle bag area
    ¸¸³²¸é
  • skip area
    °Ç³Ê¶Ú °÷
  • speech area
    ¾ð¾î¿µ¿ª
  • WAN (wide area network)
    ±¤¿ªÅë½Å¸Á
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RAS   1) Reticular Activating(Activation) System
  2) Renal Artery Stenosis
ARAS ascending reticular activating system
DMRF dorsal medullary reticular formation
LRN lateral reticular nucleus
PPRF paramedian pontine reticular formation; postpartum renal failure
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LRN lateral reticular nucleus
mPRF medial pontine reticular formation
MRF medullary reticular formation
MRF midbrain reticular formation
PPRF paramedial pontine reticular formation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • descending inhibitory system
    ÇÏÇà ¾ïÁ¦°è
  • effector-inhibitory factor
    È¿°ú±â ¾ïÁ¦ ÀÎÀÚ
  • inhibitory
    ¾ïÁ¦¼º
    °úÁ¤À» ¾ïÁ¦ ¶Ç´Â ÀúÁöÇÏ´Â. ºÎºÐÀûÀ¸·Î ¶Ç´Â ¿ÏÀüÈ÷ Á¤Ã¼, Á¤Áö½ÃŰ´Â.
  • inhibitory afferent input
    ¾ïÁ¦¼º ±¸½É¼º ÀÔ·Â
  • inhibitory contribution
    ¾ïÁ¦¼º ºÐÆ÷
  • inhibitory hormone
    ¾ïÁ¦ È£¸£¸ó
    Ç¥Àû ±â°ü¿¡ ´ëÇÏ¿© ¾ïÁ¦ÀûÀ¸·Î ÀÛ¿ëÇϴ ȣ¸£¸ó.
  • inhibitory input
    ¿ªÁ¦¼º ÀÔ·Â
  • inhibitory interneuron
    ¾ïÁ¦ °³Àç ´º¿ì·±
  • inhibitory output cell
    ¾ïÁ¦ Ãâ·Â ¼¼Æ÷
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
    ¾ïÁ¦¼º ±¸½É·Î¿¡ ÀÏÁ¦È÷ Ãæµ¿ÀÌ °¡ÇØÁú ¶§ ½Ã³À½º ÈÄ ´º·Ð¿¡ ¹ßÇàÇÏ´Â ¸·ÀüÀ§ÀÇ Àϰú¼º °úºÐ±ØÀ̸ç, ÀÌ ¶§¹®¿¡ ½Å°æ ´ÜÀ§ÀÇ ¹ÝÀÀ¼ºÀÌ °¨¾àµÈ´Ù.
  • inhibitory substantia gelatinosa cell
    ¾ïÁ¦¼º ±³¾çÁú ¼¼Æ÷
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º
  • light touch inhibitory
    ºÒºû ÀÚ±Ø ¾ïÁ¦
  • macrophage migration inhibitory factor
    ´ë½Ä ¼¼Æ÷ À¯ÁÖ ÀúÁö ÀÎÀÚ, °Å½Ä ¼¼Æ÷ À¯ÁÖ ¾ïÁ¦ ÀÎÀÚ
  • migration inhibitory factor test
    À¯ÁÖ ÀúÁö ÀÎÀÚ ½ÃÇè
    ƯÀÌ Ç׿ø¿¡ ¹ÝÀÀÇÏ¿© ¸²ÇÁ±¸°¡ MIF¸¦ »ý¼ºÇÏ´Â µ¥ ´ëÇÑ »ýüÀÇ ½ÃÇè¹ýÀ¸·Î ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» Æò°¡ÇÏ´Â µ¥ »ç¿ëÇÑ´Ù. ÀϺΠ¸é¿ª °áÇÌ Áúº´, Áï DiGeorge ÁõÈıº, Wiskott-Aldrich ÁõÈıº, Hodgkin º´¿¡¼­´Â MIF°¡ »ý¼ºµÇÁö ¾Ê´Â´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
reticular <anatomy> Pertaining to or resembling a net.
(16 Dec 1997)
reticular activating system <physiology> A physiological term denoting that part of the brainstem reticular formation that plays a central role in the organism's bodily and behavorial alertness.
It extends as a diffusely organised neural apparatus through the central region of the brainstem into the subthalamus and the intralaminar nuclei of the thalamus; by its ascending connections it affects the function of the cerebral cortex in the sense of behavioural responsiveness; its descending (reticulospinal) connections transmit its activating influence upon bodily posture and reflex mechanisms (e.g., muscle tonus), in part by way of the gamma motor neurons.
See: reticular formation.
Synonym: non-specific system.
(05 Mar 2000)
reticular cartilage <anatomy> Rarely used terms for fibrocartilage.
(05 Mar 2000)
reticular cell A cell with processes making contact with those of other similar cell's to form a cellular network; along with the network of reticular fibres, the reticular cell's form the stroma of bone marrow and lymphatic tissues.
(05 Mar 2000)
reticular degeneration <ophthalmology> Severe epidermal oedema resulting in multilocular bullae.
(05 Mar 2000)
reticular dystrophy of cornea <ophthalmology> Bilateral, progressive, superficial degeneration of the corneal epithelium and adjacent Bowman's membrane.
(05 Mar 2000)
reticular erythematous mucinosis <syndrome> A reticular erythematous dermatitis of the upper trunk, more common in women, in which there is perivascular infiltrate of lymphocytes, few plasma cells, and upper dermal deposits of mucin; worsens on exposure to ultraviolet light.
Synonym: reticular erythematous mucinosis.
(05 Mar 2000)
reticular fibre <cell biology> A fine fibre of reticulin found in the extracellular matrix.
They are fibres of type III collagen which form the distinctive loose connective tissue stroma of embryonic tissues, mesenchyme, red pulp of the spleen, cortex and medulla of lymph nodes, and the haematopoietic compartments of bone marrow and comprise a substantial portion of the collagen fibres of the skin, blood vessels, synovial membrane, uterine tissue, and granulation tissue.
They are characterised by their organization as a reticular meshwork of fine filaments and an affinity for silver and for periodic acid-Schiff stains.
(17 Jul 2002)
reticular formation <anatomy, neurology> A region extending from the pons & medulla oblongata through the mesencephalon, characterised by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fibre network.
(12 Dec 1998)
reticular lamina A major component of the basement membrane, as seen by light microscopy; it consists largely of reticular fibres and ground substances.
(05 Mar 2000)
reticular layer of corium The thicker deep layer of the corium consisting of dense irregularly arranged connective tissue.
Synonym: reticular layer of corium, stratum reticulare cutis, tunica propria corii.
(05 Mar 2000)
reticular membrane The membrane formed by cuticular plates of the cells of the spiral organ of Corti; it appears netlike when viewed from above.
Synonym: membrana reticularis.
(05 Mar 2000)
reticular nuclei of the brainstem The vaguely delineated cell groups composing the gray matter of the reticular formation of the rhombencephalon and mesencephalon. In general, large-celled territories occupy the medial two-thirds of the reticular formation: gigantocellular nucleus of medulla oblongata, nuclei tegmenti pontis caudalis and oralis. Smaller groups of reticular nuclei are found laterally and in paramedian locations; lateral nuclei receive sensory collaterals and project medially; paramedian reticular nuclei largely project to the cerebellum.
See: reticular formation.
(05 Mar 2000)
reticular nucleus of thalamus A sheet of fairly large neurons covering the lateral, ventral, and rostral surfaces of the thalamus; its reticular appearance is caused by the numerous fascicles of the thalamic peduncles which traverse the nucleus The nucleus receives numerous fibres from the cerebral cortex but it has no cortical projection.
Synonym: nucleus reticularis thalami.
(05 Mar 2000)
reticular substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dollar area
    (°æ)´Þ·¯ Áö¿ª
  • dry area
    (°Ç)µå¶óÀÌ ¿¡¾î¸®¾î(ÁöÇϽÇÀÇ È¯±â,䱤À» À§ÇÏ¿© ¸¸µé¾î ³õÀº µµ¶û)
  • elemental area
    È­¼Ò(ÅÚ·¹ºñÁ¯ È­¸éÀÇ Á÷»ç°¢Çü ±¸¿ª)
  • fringe area
    ÇÁ¸°Áö¿¡¾î¸®¾î(¶óµð¿À ÅÚ¸®ºñÁ¯ÀÇ ½Ãû ºÒ·® Áö¿ª)
  • goal area
    °ñ¿¡¾î¸®¾î
  • gray area
    (¾ç±Ø »çÀÌÀÇ)Áß°£ ¿µ¿ª;À̵µÀúµµ ¾Æ´Ñ(¾Ö¸ÅÇÑ)ºÎºÐ(»óȲ);=GREY AREA
  • grey area
    Á¤½Ä ¿øÈ£ ´ë»óÀº ¾Æ´Ï³ª ½Ç¾÷·üÀÌ ³ôÀº Áö¿ª;=GRAY AREA
  • impact area
    (ÆøÅº,¹Ì»çÀÏÀÇ)ÀÛ·ÂÁö¿ª;ÂøÅºÁö¿ª
  • impacted area
    Àα¸ ±ÞÁõÁö±¸
  • jump area
    (³«ÇÏ»ê ºÎ´ëÀÇ)³«ÇÏ ¿¹Á¤Áö (ÀûÁøÀÇ ÈĹæ)
  • metropolitan area
    (´ë)µµ½Ã±Ç
  • penalty area
    ¹úÄ¢ ±¸¿ª
  • resistance area
    =RESISTANCE LEVEL
  • restricted area
    ÃâÀÔ(ÅëÇà)±ÝÁö ±¸¿ª
  • service area
    ¾ç(½Ã)û ±¸¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á